Clinical Trial Update: Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and reactogenicity of a monovalent Haemophilus influenzae type b conjugate vaccine. The study sponsored by Novartis Vaccines is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Haemophilus influenzae type b vaccine (monovalent conjugate) (Haemophilus influenzae type b vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Haemophilus Influenzae Type b | Phase 1 | Status: COMPLETED